Holen Sie sich die Stockscreener-App
404.07
1.23%
4.89
Handel nachbörslich:
404.07
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
Insider Sell: Dixon Robert L JR Sells Shares of Elevance Health Inc (ELV) - GuruFocus
Form 144: Ronald Penczek sale of 1,531 ELV shares (ELV) - Stock Titan
Elevance Health (ELV) director reports open-market sale of common stock - Stock Titan
[144] Elevance Health, Inc. SEC Filing - Stock Titan
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Morgan Stanley (MS) issues 300% leveraged PLUS tied to Elevance Health (ELV) stock - Stock Titan
Elevance Health Inc (ELV) Shares Fall 4.7% -- What GF Score of 9 - GuruFocus
Elevance Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Elevance Health Inc Stock (ELV) Moved Down by 5.03% on Jun 10: Facts Behind the Movement - TradingKey
Elevance Health (ELV) Reaffirms 2026 Earnings and Expense Guidan - GuruFocus
Elevance Health (ELV) slides as investors refocus on CMS compliance overhang ahead of key late-June deadline - Quiver Quantitative
Elevance Health Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Elevance Health Reaffirms 2026 Adjusted EPS Guidance - marketscreener.com
(ELV) Elevance Health Expects 2026 Adjusted EPS At Least $26.75, vs. FactSet Est of $26.85 - marketscreener.com
[8-K] Elevance Health, Inc. Reports Material Event - Stock Titan
Elevance Health stock: Is ELV underperforming the health care sector? - MSN
Elevance Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Elevance files lawsuit against former executive for noncompete violation - The Indiana Lawyer
Morgan Stanley (MS) launches 1‑year 300%‑leveraged PLUS on ELV with $1,370.50 cap - Stock Titan
Elevance Health stock hits 52-week high at 422.65 USD By Investing.com - Investing.com Nigeria
Elevance Health stock hits 52-week high at 422.65 USD - Investing.com
Are Wall Street analysts predicting Elevance stock will climb or sink? - MSN
JPMorgan Adjusts Price Target on Elevance Health to $476 From $411, Maintains Overweight Rating - marketscreener.com
ELV Stock Quote Price and Forecast - CNN
Medicare Advantage in 2026: Enrollment Update and Key Trends - KFF
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers Stocks - Yahoo Finance
UnitedHealth Stock Jumps 20% YTD: Should Investors Jump in Too? - TradingView
Elevance Health Inc (ELV) Stock Price, Trades & News - GuruFocus
How Investors Are Reacting To Elevance Health (ELV) Expanding Digital Access For Underserved Patients - simplywall.st
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $406.38, Implies 4% Upside - TradingView
UnitedHealth Prescribes Another Dividend Increase: Just a Lighter Dose - TradingView
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $405.19, Implies 4% Upside - TradingView
Chutes & Ladders—Ardent Health appoints new CEO; KFF Founding President, CEO to retire - Fierce Healthcare
Elevance Health’s Digital Equity Push Reframes Virtual Care And Investor Narrative - Yahoo Finance
Collis buys Elevance Health (ELV) shares worth $869,519 By Investing.com - Investing.com Nigeria
Elevance Health Inc (ELV) Shares Fall 3.4% -- What GF Score of 8 - GuruFocus
Elevance Health Inc (ELV) Shares Fall 3.4% -- What GF Score of 89 Tells Investors - GuruFocus
Elevance Health Outperforms Sector Market in Early 2026 - asatunews.co.id
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Collis buys Elevance Health (ELV) shares worth $869,519 - Investing.com
Elevance Health Price Target Raised to $450.00/Share From $375.00 by Truist Securities - Moomoo
Elevance again avoids Medicare Advantage sanctions, but threat remains - Healthcare Dive
Elevance Health: Making The Bull Case For Ongoing Recovery (Rating Upgrade) (NYSE:ELV) - Seeking Alpha
Elevance Health Stock: Is ELV Underperforming the Health Care Sector? - Barchart
Truist Raises Price Target on Elevance Health to $450 From $375, Keeps Buy Rating - Moomoo
Elevance Health, Inc. (ELV) Stock Analysis: Navigating Growth In The Healthcare Sector - DirectorsTalk Interviews
Elevance Health Secures Spot on Evercore Tactical Outperform List - asatunews.co.id
Elevance Health (ELV): One of the Best Undervalued Stocks to Buy According to the Financial Media - Insider Monkey
Elevance Health gains as Medicare sanctions risk abates - MSN
What Does Elevance Health's Q1 2026 Performance Signal for Investors - Kavout
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):